Winton Group’s Dermira, Inc. DERM Stock Holding History

Winton Group’s Portfolio DERM Stock Details DERM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-10,207	Closed	-$65K	–	1873
2019 Q3	$65K	Buy	+10,207	New	+$85.2K	﹤0.01%	1486

Other funds holding DERM

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Winton Group's DERM Position: Q4 2019 in Review

Winton Group sold out of Dermira, Inc. (DERM) in Q4 2019, closing a stake of 10,207 shares — an estimated $65K sold.

Winton Group first reported a position in DERM in Q3 2019 and held it in 1 quarter. The position peaked at $65K in Q3 2019. 133 funds tracked by Wall St. Rank hold DERM as of Q4 2019.

Winton Group reported no remaining Dermira, Inc. position as of Q4 2019 after selling out during the quarter.
Winton Group sold 10,207 Dermira, Inc. shares in Q4 2019, an estimated $65K.
Winton Group first reported a position in Dermira, Inc. in Q3 2019 and held it in 1 quarter.
Winton Group's Dermira, Inc. position peaked at $65K in Q3 2019.
133 funds tracked by Wall St. Rank held Dermira, Inc. as of Q4 2019.

Based on Winton Group's 13F filing for Q4 2019, filed 13 Feb 2020.